Trial Profile
Pharmacokinetics of dalbavancin in bone and associated tissues in patients undergoing orthopedic surgery
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Dalbavancin (Primary)
- Indications Bacterial infections; Bone and joint infections; Postoperative infections; Skin and soft tissue infections
- Focus Pharmacokinetics
- Sponsors Durata Therapeutics
- 27 Nov 2015 New trial record